)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Neola Medical
Neola Medical (NEOLA) investor relations material
Neola Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Feb, 2026
Executive summary
Entered clinical phase in 2025, launching the first clinical pilot study on preterm infants in Sweden and preparing for U.S. pivotal trials.
Expanded leadership team, including a Director of Disposable Product Development, and strengthened the patent portfolio with seven new grants in 2025.
Established collaborations with leading U.S. hospitals and key opinion leaders to support clinical adoption.
Financial highlights
Completed a directed share issue of approximately SEK 20 million in H1 2025, attracting institutional investors.
Full-year 2025 operating result was SEK -11,093k, with Q4 operating result at SEK -2,520k.
Cash and cash equivalents at year-end were SEK 16,123k.
Costs for 2025 were slightly lower than the previous year due to reduced need for external consultants.
Result per share for 2025 was -0.14 SEK.
Outlook and guidance
U.S. remains the primary target market, with commercialization strategy focused on top 10 children's hospitals.
European market (Nordics, Ireland, France) is the next priority, with CE mark application in preparation.
Clinical pilot study in Sweden expected to complete enrollment in Q1 2026, with full data analysis to follow.
Burn rate expected to increase as clinical validation accelerates and commercial structure preparations continue.
No dividend proposed for 2025.
U.S. market niche strategy and scaling
Neola optimization needs from Sweden study
International studies: expected cost impact
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Neola Medical
- Clinical validation, FDA milestones, and US market entry drive strong financial outlook.NEOLA
Q2 20241 Feb 2026 - Advanced to clinical validation, secured patents, and targets U.S. market launch in 2026.NEOLAQ3 202416 Jan 2026
- Advanced to clinical phase with regulatory progress, strong equity, and U.S. market focus.NEOLAQ4 202424 Dec 2025
- U.S. pivotal study site secured, Swedish pilot underway, SEK 20m raised, strong equity and IP.NEOLAQ2 202523 Nov 2025
- Clinical pilot study advances, robust safety data, and SEK 20M raised; U.S. study delayed.NEOLAQ3 20254 Nov 2025
- Q1 2025 saw Neola Medical secure funding, enroll its first clinical patient, and strengthen its IP.NEOLAQ1 20256 Jun 2025
Next Neola Medical earnings date
Q1 202619 May, 2026
Neola Medical
Next Neola Medical earnings date
Q1 202619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage